Hypothesis Comparison

⚛ Collide these ⚔ Judge as Duel

Comparing 2 hypotheses side-by-side

|

Calibrated PLCG2 activation can reproduce the protective rs72824905 microglial s

PLCG2 · Alzheimer's disease · therapeutic_genetics
Composite
0.650
Price
$0.65
Evidence For
0
Evidence Against
0

The ad_genetic_risk_loci dataset identifies PLCG2 rs72824905 as a rare protective AD variant with a strong protective odds-ratio proxy. The notebook's Enrichr and GTEx analysis places PLCG2 in a microglial immune signaling module with actionable phospholipase biology. Hypothesis: partial, pathway-biased PLCG2 activation can increase microglial plaque and debris clearance while avoiding broad inflammatory gain-of-function toxicity.

Rare TREM2-TYROBP pathway variants complement standard PRS by identifying microg

PLCG2 · Late-onset Alzheimer's disease · translational
Composite
0.000
Price
$0.50
Evidence For
0
Evidence Against
0

We hypothesize that rare loss-of-function variants in microglial-expressed genes within the TREM2-TYROBP signaling cascade (PLCG2, TREM2, INPP5D, APOC2) capture a distinct late-onset Alzheimer's disease etiological subtype characterized by dysregulated microglial lipid sensing and enhanced synaptic pruning that is not captured by standard AD polygenic risk scores. This rare variant burden identifies individuals with enhanced microglial-driven neurodegeneration who fall below PRS risk thresholds,

Convergent vs Divergent Predictions

This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.

PLCG2Microglial DysfunctionMicroglial Immunity
Convergent signals
  • PLCG2 recurs across 2 selected hypotheses with aligned directionality in microglial dysfunction, microglial immunity.
Divergent signals
  • No direct polarity conflicts detected among the selected hypotheses.

Verdict Summary

7/11
dimensions won
Calibrated PLCG2 activation can reproduc
4/11
dimensions won
Rare TREM2-TYROBP pathway variants compl

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic
0.70
0.00
Evidence
0.66
0.72
Novelty
0.64
0.68
Feasibility
0.58
0.78
Impact
0.72
0.00
Druggability
0.76
0.00
Safety
0.46
0.00
Competition
0.00
0.00
Data
0.78
0.00
Reproducible
0.62
0.00
KG Connect
0.50
0.50

Score Breakdown

DimensionCalibrated PLCG2 activation caRare TREM2-TYROBP pathway vari
Mechanistic0.7000.000
Evidence0.6600.720
Novelty0.6400.680
Feasibility0.5800.780
Impact0.7200.000
Druggability0.7600.000
Safety0.4600.000
Competition0.0000.000
Data0.7800.000
Reproducible0.6200.000
KG Connect0.5000.500

Evidence

Calibrated PLCG2 activation can reproduce the protective rs7

No evidence citations yet

Rare TREM2-TYROBP pathway variants complement standard PRS b

No evidence citations yet

Price History Overlay